Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig Hyde

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Ebiomedicine|July 1, 2025
Integrated virologic analysis of resistance to nirmatrelvir/ritonavir in individuals across four phase 2/3 clinical studies for the treatment of COVID-19Mary Lynn Baniecki, Shunjie Guan, Devendra K Rai, et al.
The Journal of Allergy and Clinical Immunology|September 30, 2023
Improvements in immune/melanocyte biomarkers with JAK3/TEC family kinase inhibitor ritlecitinib in vitiligoEmma Guttman-Yassky, Ester Del Duca, Joel Correa Da Rosa, et al.
Arthritis and Rheumatism|September 10, 2011
Large candidate gene association study reveals genetic risk factors and therapeutic targets for fibromyalgiaShad B Smith, Dylan W Maixner, Roger B Fillingim, et al.
Pain|July 26, 2016
Genome-wide association analysis of pain severity in dysmenorrhea identifies association at chromosome 1p13.2, near the nerve growth factor locusAmy V Jones, James R F Hockley, Craig Hyde, et al.
Acta Neuropathologica Communications|November 8, 2019
Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer's diseaseChristopher D Whelan, Niklas Mattsson, Michael W Nagle, et al.
Experimental Dermatology|September 20, 2024
Efficacy and safety of ritlecitinib in vitiligo patients across Fitzpatrick skin types with biomarker analysesElena Peeva, Yuji Yamaguchi, Zhan Ye, et al.
Human Molecular Genetics|February 16, 2017
GWAS of self-reported mosquito bite size, itch intensity and attractiveness to mosquitoes implicates immune-related predisposition lociAmy V Jones, Mera Tilley, Alex Gutteridge, et al.
Arthritis Research & Therapy|June 6, 2024
A Phase 1, randomized, double-blind, placebo-controlled, single- and multiple-dose escalation study to evaluate the safety and pharmacokinetics/pharmacodynamics of PF-06835375, a C-X-C chemokine receptor type 5 directed antibody, in patients with systemic lupus erythematosus or rheumatoid arthritisStanley Cohen, Jean S Beebe, Vishala Chindalore, et al.
European Heart Journal|June 29, 2026
Cardiac remodelling and dysfunction in cancer patients receiving cardiotoxic therapies: proteomic and metabolomic profilingBonnie Ky, Congying Xia, Kyunga Ko, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|January 10, 2025
Genome-wide association study of varenicline-aided smoking cessationKayesha Coley, Qingning Wang, Richard Packer, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Ebiomedicine|July 1, 2025
Integrated virologic analysis of resistance to nirmatrelvir/ritonavir in individuals across four phase 2/3 clinical studies for the treatment of COVID-19Mary Lynn Baniecki, Shunjie Guan, Devendra K Rai, et al.
The Journal of Allergy and Clinical Immunology|September 30, 2023
Improvements in immune/melanocyte biomarkers with JAK3/TEC family kinase inhibitor ritlecitinib in vitiligoEmma Guttman-Yassky, Ester Del Duca, Joel Correa Da Rosa, et al.
Arthritis and Rheumatism|September 10, 2011
Large candidate gene association study reveals genetic risk factors and therapeutic targets for fibromyalgiaShad B Smith, Dylan W Maixner, Roger B Fillingim, et al.
Pain|July 26, 2016
Genome-wide association analysis of pain severity in dysmenorrhea identifies association at chromosome 1p13.2, near the nerve growth factor locusAmy V Jones, James R F Hockley, Craig Hyde, et al.
Acta Neuropathologica Communications|November 8, 2019
Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer's diseaseChristopher D Whelan, Niklas Mattsson, Michael W Nagle, et al.
Experimental Dermatology|September 20, 2024
Efficacy and safety of ritlecitinib in vitiligo patients across Fitzpatrick skin types with biomarker analysesElena Peeva, Yuji Yamaguchi, Zhan Ye, et al.
Human Molecular Genetics|February 16, 2017
GWAS of self-reported mosquito bite size, itch intensity and attractiveness to mosquitoes implicates immune-related predisposition lociAmy V Jones, Mera Tilley, Alex Gutteridge, et al.
Arthritis Research & Therapy|June 6, 2024
A Phase 1, randomized, double-blind, placebo-controlled, single- and multiple-dose escalation study to evaluate the safety and pharmacokinetics/pharmacodynamics of PF-06835375, a C-X-C chemokine receptor type 5 directed antibody, in patients with systemic lupus erythematosus or rheumatoid arthritisStanley Cohen, Jean S Beebe, Vishala Chindalore, et al.
European Heart Journal|June 29, 2026
Cardiac remodelling and dysfunction in cancer patients receiving cardiotoxic therapies: proteomic and metabolomic profilingBonnie Ky, Congying Xia, Kyunga Ko, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|January 10, 2025
Genome-wide association study of varenicline-aided smoking cessationKayesha Coley, Qingning Wang, Richard Packer, et al.
Pageof 3